Monica G. Ormerod
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Minor immunomodulatory effects of psychotropics suggested in severe mental disorders: Associations of antipsychotics with beta defensin 2, antidepressants with C-reactive protein, and mood stabilizers with soluble interleukin 2 receptor.
Journal: European psychiatry : the journal of the Association of European Psychiatrists
Published: September 12, 2025
Limited evidence of association between dysregulated immune marker levels and telomere length in severe mental disorders.
Journal: Acta neuropsychiatrica
Published: January 23, 2025
Toxoplasma gondii associated with psychotic symptom load and cortisol in severe mental illness.
Journal: Schizophrenia (Heidelberg, Germany)
Published: December 26, 2024
Cortisol and C-reactive protein (CRP) regulation in severe mental disorders.
Journal: Psychoneuroendocrinology
Published: August 31, 2024
Telomere biology and its maintenance in schizophrenia spectrum disorders: Exploring links to cognition.
Journal: Schizophrenia research
Published: March 12, 2024
Sex differences in autonomic adverse effects related to antipsychotic treatment and associated hormone profiles.
Journal: Schizophrenia (Heidelberg, Germany)
Published: November 09, 2023
Cognitive and inflammatory heterogeneity in severe mental illness: Translating findings from blood to brain.
Journal: Brain, behavior, and immunity
Published: November 02, 2023
Toxoplasma gondii infection associated with inflammasome activation and neuronal injury.
Journal: Scientific reports
Published: September 24, 2023
Telomere length and verbal learning in bipolar disorders.
Journal: Journal of affective disorders
Published: March 19, 2023
Elevated Systemic Levels of Markers Reflecting Intestinal Barrier Dysfunction and Inflammasome Activation Are Correlated in Severe Mental Illness.
Journal: Schizophrenia bulletin
Published: December 03, 2022
Last Updated: 09/26/2026